Home › Stomach Cancer
Stomach Cancer clinical trials recruiting in the U.S.
132 studies for Stomach Cancer are recruiting participants at sites across the United States.
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
Cities with the most studies
- Houston, TX41 studies
- Boston, MA31 studies
- New York City, NY30 studies
- Nashville, TN27 studies
- Los Angeles, CA21 studies
- Baldwin Park, CA21 studies
- San Antonio, TX19 studies
- Arlington, VA19 studies
- Dallas, TX18 studies
- St. Louis, MO18 studies
- Grand Rapids, MI18 studies
- Chicago, IL16 studies
- Washington, DC16 studies
- Philadelphia, PA15 studies
- Detroit, MI15 studies
- Atlanta, GA14 studies
- Pittsburgh, PA14 studies
- Orange, CA13 studies
- Mountain View, CA12 studies
- Cleveland, OH12 studies
- Portland, OR11 studies
- Denver, CO11 studies
- Seattle, WA10 studies
- Durham, NC10 studies
- Queens, NY10 studies
- Madison, WI10 studies
- Aurora, CO10 studies
- Edison, NJ10 studies
- Oklahoma City, OK10 studies
- Austin, TX10 studies
- Orlando, FL10 studies
- Omaha, NE9 studies
- Tampa, FL9 studies
- Columbus, OH9 studies
- Kansas City, MO9 studies
- Minneapolis, MN9 studies
- Rochester, MN9 studies
- San Diego, CA9 studies
- New Haven, CT8 studies
- Baltimore, MD8 studies
By state
- Alabama6 studies
- Alaska4 studies
- Arizona12 studies
- Arkansas6 studies
- California67 studies
- Colorado22 studies
- Connecticut10 studies
- Delaware4 studies
- District of Columbia4 studies
- Florida38 studies
- Georgia16 studies
- Idaho3 studies
- Illinois19 studies
- Indiana10 studies
- Iowa8 studies
- Kansas8 studies
- Kentucky9 studies
- Louisiana4 studies
- Maine3 studies
- Maryland20 studies
- Massachusetts33 studies
- Michigan34 studies
- Minnesota18 studies
- Missouri23 studies
- Montana4 studies
- Nebraska9 studies
- Nevada5 studies
- New Jersey12 studies
- New Mexico5 studies
- New York37 studies
- North Carolina21 studies
- North Dakota4 studies
- Ohio23 studies
- Oklahoma11 studies
- Oregon12 studies
- Pennsylvania30 studies
- Rhode Island5 studies
- South Carolina9 studies
- South Dakota4 studies
- Tennessee29 studies
- Texas59 studies
- Utah14 studies
- Virginia26 studies
- Washington14 studies
- West Virginia4 studies
- Wisconsin17 studies
Recently updated studies
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 28, 2026 · NCT06586957Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07392892IKS014 in Advanced Solid Tumors That Express HER2
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05872295A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06005493Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT05523947A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07069712Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecruitingPhase 2
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT05489211A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07631000A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Prehabilitation in High-risk Oncologic Surgery
Recruiting
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07638410Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05274048Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05267626A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07705334Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07217704A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07578571EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06263088A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07818018Resilience and Equity in Aging, Cancer, and Health (REACH)
Recruiting
Ages 65 and older · All sexes · Updated Sep 10, 2026 · NCT04674267SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07812805Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07360314From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.